Skip to content

Clinical trials

Phase 2 Digestive System Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Neoplasms Phase: Phase 2 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20111
20161
20173
20211
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NanOlogy, LLC2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Boston Scientific Corporation1
Genentech, Inc.1
H. Lee Moffitt Cancer Center and Research Institute1
Hoffmann-La Roche1
Kumquat Biosciences Inc.1
Novartis Pharmaceuticals1
Thomas Jefferson University1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Neoplasms12
Digestive System Diseases8
Neoplasms6
Neoplasms by Site6
Pancreatic Neoplasms5
Gastrointestinal Diseases4
Gastrointestinal Neoplasms4
Pancreatic Diseases4
Adenocarcinoma3
Carcinoma3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.